Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies
Chirag Bavishi, Paul K. Whelton, Giuseppe Mancia, et al.
Journal of Hypertension (2021) Vol. 39, Iss. 4, pp. 784-794
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1435
Hypertension and COVID-19: Current Evidence and Perspectives
Giovanna Gallo, Valentin Calvez, Carmine Savoia
High Blood Pressure & Cardiovascular Prevention (2022) Vol. 29, Iss. 2, pp. 115-123
Open Access | Times Cited: 109
Coronavirus disease 2019 and cardiovascular complications: focused clinical review
Sahrai Saeed, Marijana Tadić, Terje H. Larsen, et al.
Journal of Hypertension (2021) Vol. 39, Iss. 7, pp. 1282-1292
Open Access | Times Cited: 81
Hypertension, a Moving Target in COVID-19
Carmine Savoia, Massimo Volpe, Reinhold Kreutz
Circulation Research (2021) Vol. 128, Iss. 7, pp. 1062-1079
Open Access | Times Cited: 78
Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension
Sonali R. Gnanenthiran, Claudio Borghi, Dylan Burger, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 17
Open Access | Times Cited: 44
The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
Yidan Chen, Xingfei Lv, Sang Lin, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33
Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets
J. Pedro Teixeira, Sharon Barone, Kamyar Zahedi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2242-2242
Open Access | Times Cited: 27
The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
Mikael Ekholm, Thomas Kahan
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39
Mortality risk factors in a Spanish cohort of oldest-old patients hospitalized with COVID-19 in an acute geriatric unit: the OCTA-COVID study
Isabel Lozano-Montoya, Maribel Quezada-Feijoó, Javier Tamayo Jaramillo, et al.
European Geriatric Medicine (2021) Vol. 12, Iss. 6, pp. 1169-1180
Open Access | Times Cited: 30
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 19
Effect of continuing the use of renin–angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta-analysis, and meta-regression analysis
Qi Liu, Wei Fu, Changju Zhu, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic
Lanfranco D’Elia, Alfonso Giaquinto, Aquilino Flavio Zarrella, et al.
European Journal of Internal Medicine (2022) Vol. 108, pp. 28-36
Open Access | Times Cited: 15
Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice
Steven Brooks, Rachel L. Smith, Aline dos Santos Moreira, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
Giuseppe Remuzzi, Stefano Schiaffino, Maria Gabriella Santoro, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Research strategies in treatment of hypertension: value of retrospective real-life data
Giovanni Corrao, Giuseppe Mancia
European Heart Journal (2021) Vol. 43, Iss. 35, pp. 3312-3322
Closed Access | Times Cited: 14
Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure
Alberto Aimo, Giuseppe Vergaro, Claudio Passino, et al.
Critical Reviews in Clinical Laboratory Sciences (2021) Vol. 58, Iss. 8, pp. 530-545
Closed Access | Times Cited: 13
Hypertension management: The lesson from the SARS-CoV-2 pandemic
Lanfranco D’Elia
European Journal of Internal Medicine (2024)
Closed Access | Times Cited: 1
Is Lone Hypertension a Risk Factor for More Severe COVID-19 Outcomes?
E. Shalaeva, Alisher Shadmanov, Feruza Azizova, et al.
Global Heart (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Renin–angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study
Matteo Landolfo, Alberto Maino, Emanuela Di Salvo, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 5, pp. 1335-1341
Open Access | Times Cited: 7
COVID-19-Patientinnen und -Patienten in Deutschland: Expositionsrisiken und assoziierte Faktoren für Hospitalisierungen und schwere Krankheitsverläufe
Uwe Koppe, Hendrik Wilking, Thomas Harder, et al.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2021) Vol. 64, Iss. 9, pp. 1107-1115
Open Access | Times Cited: 9
Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality
Malindu E. Fernando, Aaron Drovandi, Jonathan Golledge
Systematic Reviews (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review
Nathalie Gault, Marina Esposito‐Farèse, Matthieu Revest, et al.
Fundamental and Clinical Pharmacology (2021) Vol. 35, Iss. 6, pp. 1141-1158
Open Access | Times Cited: 7
All that Glitters: Money Laundering Through Precious Metals and Minerals
Yuliya Zabyelina, Lilla Heins
Springer eBooks (2020), pp. 439-465
Closed Access | Times Cited: 6
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab
Steven M. Smith, Raj Desai, Marta Walsh, et al.
American Heart Journal Plus Cardiology Research and Practice (2022) Vol. 13, pp. 100112-100112
Open Access | Times Cited: 4
CORTICOIDES E SUA INFLUÊNCIA NA ALTERAÇÃO DA PRESSÃO ARTERIAL
Laura Vieira de Lima Costa, Raimunda Edinalva Sousa Da Silva, João Alberto de Oliveira Campos
Revista Saúde dos Vales (2024) Vol. 11, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top